InvestorsHub Logo
icon url

Noemotionseller

05/19/17 12:17 PM

#54159 RE: Bristol19 #54156

Many different opinions here on the r/s. But some things are undeniably true. Market makers will still exist. They will just be different. No matter the market there will be those that don't give s shit about the company long term but will take the opportunity to make money off the fluctuations ( manipulated or not). The other truth is we will have not only more institutional support but all the individual potential support and NEW interest as well. How many of us have been told by brokers either directly or indirectly that this and the OTC is toooo risky and they would not advise it? Well we are the few that didn't listen. If this is uplisted to a respectable market and people read that we are a year from FDA submission of a new and unique robotic platform, I can't help believe there will be new interest. If MMs manage to bring the price down so they can gobble up cheap shares just to let it run, you have only lost money if you sell when it is cheap. The only reason they would drive the price down would be knowing they can tap into fear. BUT if the company is good. If there is promise, they will be buying and so should we. Because at a MC in the BILLIONS as a potential there is money to be made here. Lots of it. Maybe not the 1-3000% we might have dreamed of but some good returns. Looking at the size of our investments here we can influence the price by panicking and selling. We can win or lose with timing or investment. Collectively this board has more than 30 times the average daily volume. You only lose if you sell or if the company fails. Every anecdotal example of a company that either succeeded or failed with a r/s is a unique situation. The future will not translate. We have the perfect example of failure with trxc. CRAP PRODUCT. We are not crap. Many in the medical field are here because we know it is not crap. If we get money to FDA and we submit by end of 2018 as promised, we are golden. If we could do that in the OTC, we would be golden. It looks like mgt has a few options to consider and I bet it has to do with investment bankers...
icon url

devicerep888

05/19/17 12:58 PM

#54164 RE: Bristol19 #54156

RS doesn't change market cap. Market cap is severely undervalued. Get off crap OTC and onto NASDAQ and if you have constant established institutional investors buying stock it frantically changes demand. Combined with less shares outstanding could provide catalyst we've always wanted as investors. Bottom line is market cap is currently 55 million, so much upside.